Transcription of REQUEST FOR INFORMATION IMPROVED NERVE …
{{id}} {{{paragraph}}}
IMPROVED NERVE Agent Treatment System (INATS) MMB4 RFI 18-08 Page 1 of 3 REQUEST FOR INFORMATION IMPROVED NERVE AGENT TREATMENT SYSTEM (INATS) MMB4 DEPARTMENT OF DEFENSE SOLUTION TO DEVELOP AN IMPROVED OXIME WITH INCREASED EFFICACY AGAINST NERVE AGENTS Objective: This is a REQUEST for INFORMATION (RFI) for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the INFORMATION solicited. No solicitation document exists or is guaranteed to be issued as a result of this RFI. The Joint Product Manager for Chemical Defense Pharmaceuticals (JPdM CDP) at the Joint Program Executive Office for Chemical and Biological Defense (JPEO CBD) Medical Countermeasures Systems (MCS) is seeking INFORMATION on the capabilities and willingness of private entities (non-profit and commercial) in the areas listed below.
Improved Nerve Agent Treatment System (INATS) – MMB4 RFI 18-08 . Page . 1. of . 3. REQUEST FOR INFORMATION . IMPROVED NERVE …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
THE STANDARD RESPONSE PROTOCOL V2, The Standard Response Protocol, Overview of Drug Development, Protocol, PAEDIATRIC CLINICAL TRIALS GUIDANCE FOR ASSESSORS, CTD Dossier Preparation, MS-9200UDLS(E) Rev 3, Assessment report, The Investigational New Drug (IND) and, Method Development: a Guide to Basics